Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2010
11/25/2010US20100297775 Colorimetric test for antimalarial artemesin derivatives
11/25/2010US20100297774 Tagging method
11/25/2010US20100297745 Flow-through method of functionalizing inner surfaces of a microfluidic device
11/25/2010US20100297730 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297686 Devices for intracellular surface-enhanced raman spectroscopy
11/25/2010US20100297685 Methods for culturing and analyzing cells
11/25/2010US20100297680 Methods for assessing the risk for development of cardiovascular disease
11/25/2010US20100297679 Identification and quantification of biomarkers for evaluating the risk of preterm birth
11/25/2010US20100297678 Biomarkers for multiple sclerosis
11/25/2010US20100297677 Cycochrome c synthesis inhibitors
11/25/2010US20100297676 Methods for diagnosis, prognosis and methods of treatment
11/25/2010US20100297675 Substrate and method for culturing breast cells
11/25/2010US20100297674 NOVEL CELL LINES EXPRESSING NaV AND METHODS USING THEM
11/25/2010US20100297673 Methods and compositions for upregulation of peroxiredoxin activity
11/25/2010US20100297672 Highly sensitive system and methods for analysis of troponin
11/25/2010US20100297671 Method and Device for the Quantitative Determination of Analytes in Liquid Samples
11/25/2010US20100297670 Methods for detection of immunosuppressant drugs
11/25/2010US20100297669 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297668 Human e3alpha ubiquitin ligase family
11/25/2010US20100297667 Method for diagnosis of disease using quantitative monitoring of protein tyrosine phosphatase
11/25/2010US20100297666 Methods for determination of protein phosphatase activity, and uses in predicting therapeutic outcomes
11/25/2010US20100297665 Method for testing and screening p38 map kinase modifiers
11/25/2010US20100297664 Paratope and epitope of anti-mortalin antibody
11/25/2010US20100297663 Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject
11/25/2010US20100297662 Antibody and use thereof
11/25/2010US20100297661 Diagnostic Composition and Kit for Renal Cell Carcinoma
11/25/2010US20100297658 Detecting methylated mammalian nucleic acid in stool
11/25/2010US20100297657 Expression profile of prostate cancer
11/25/2010US20100297653 Methods of diagnosing and treating cancer
11/25/2010US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/25/2010US20100297646 Method for detection of cancer
11/25/2010US20100297641 Methylation altered dna sequences as markers associated with human cancer
11/25/2010US20100297639 Quantitative/semi-quantitative measurement of epor on cancer cells
11/25/2010US20100297636 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
11/25/2010US20100297635 Collection and measurement of exhaled particles
11/25/2010US20100297633 Method of amplifying nucleic acid
11/25/2010US20100297632 Upregulation of rack-1 in melanoma and its use as a marker
11/25/2010US20100297631 Compositions and Methods For Detecting Histamine Related Disorders
11/25/2010US20100297625 Biomarkers for psychosis
11/25/2010US20100297623 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
11/25/2010US20100297618 Methods for determining a prognosis of colorectal cancer
11/25/2010US20100297616 Situ hybridisation method
11/25/2010US20100297615 Egfr mutations
11/25/2010US20100297611 Method and Device For Combined Detection Of Viral And Bacterial Infections
11/25/2010US20100297608 Systems and Methods for CMOS-Compatible Silicon Nano-Wire Sensors with Biochemical and Cellular Interfaces
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297603 Analyte-releasing beads and use thereof in quantitative elispot or fluorispot assay
11/25/2010US20100297602 Apparatus and method of contaminant detection
11/25/2010US20100297532 Process for working up ionic liquids
11/25/2010US20100297291 Visible/near-infrared spectrum analyzing method and grape fermenting method
11/25/2010US20100297253 Treatment of diabetes with milk protein hydrolysate
11/25/2010US20100297215 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/25/2010US20100297183 Immunogenic streptococcus proteins
11/25/2010US20100297162 S. epidermidis antigens
11/25/2010US20100297158 Anticancer vaccine and diagnostic methods and reagents
11/25/2010US20100297153 Binding molecules for treatment and detection of cancer
11/25/2010US20100297152 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297147 Compositions and methods for modulating tlr14 activity
11/25/2010US20100297145 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
11/25/2010US20100297137 Hematopoietic Lineage Cell Specific Protein (HS1) as a Marker for Lymphoid Malignancy
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297134 Humanised antibodies with anti-tumour activity
11/25/2010US20100297133 Immunogenic Polypeptides and Monoclonal Antibodies
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297108 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
11/25/2010US20100297103 Antibody having enhanced adcc activity and method for production thereof
11/25/2010US20100297102 Serotonin 5-ht3a receptors in treatment of neurological and psychiatric disorders
11/25/2010US20100297093 Modified t cell receptors and related materials and methods
11/25/2010US20100297067 Methylation markers for prostate cancer and methods of use
11/25/2010US20100297035 Thiazole Amides, Imidazole Amides and Related Analogues
11/25/2010US20100297021 Variants of C-Type Natriuretic Peptide
11/25/2010US20100297016 Quarternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
11/25/2010US20100297013 Humanized antibody
11/25/2010US20100297012 Humanized antibody
11/25/2010US20100297011 Isolated peptides and uses thereof
11/25/2010US20100297010 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/25/2010US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297003 Anti-human tenascin monoclonal antibody
11/25/2010US20100296973 Systems and Methods for Monitoring Chemical and Biological Activity using Differential Measurements
11/25/2010US20100295685 System and Method for Automatic Quality Control of Clinical Diagnostic Processes
11/25/2010US20100294723 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
11/25/2010US20100294710 Method for producing a component, in particular a micromechanical and/or microfluidic and/or microelectronic component, and component
11/25/2010US20100294023 Propellant Ignition Testing Apparatus Having a Compressively Sealable Chamber
11/25/2010DE202009003347U1 Behälter zur Aufnahme von Nährlösungen oder Nährböden für Bakterienkulturen Container for containing nutrient solutions or nutrient media for bacterial cultures
11/25/2010DE102009021876A1 Analyzing neurite outgrowth, comprises depositing neuron and neuron-like cell on substrate having grid pattern with first- and second region on which neuron and neuron-like cell accumulate, where first region is surrounded by second region
11/25/2010DE102009015724B4 Behälter zur Sicherung, Aufbewahrung und zum Transport von biologischen Proben Container for backup, storage and transport of biological samples
11/25/2010DE102005049220B4 Verfahren und Vorrichtung zum Testen der Zerfallszeit fester Prüflinge in Flüssigkeiten Method and device for testing the disintegration time of solid samples in liquids
11/25/2010DE102005028062B4 Laser-Mikrodissektionsverfahren und Vorrichtung zur Laser-Mikrodissektion Laser microdissection method and device for laser microdissection
11/25/2010DE10014846B4 Vorrichtung zur Messung des Konditionierzustandes einer Schlamm/Flockmittel-Mischung Device for measuring the Konditionierzustandes a sludge / flocculant mixture
11/25/2010CA2800371A1 Methods of renal cancer detection
11/25/2010CA2799996A1 Systems and methods for determining the percentage of glycated hemoglobin
11/25/2010CA2799995A1 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
11/25/2010CA2764931A1 Engineered type iv pilin of clostridium difficile
11/25/2010CA2762983A1 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy
11/25/2010CA2762783A1 Methods for providing personalized medicine tests ex vivo for hematological neoplasms
11/25/2010CA2762687A1 Conjugate having cleavable linking agent
11/25/2010CA2762611A1 Blood coagulation time prolonging agent
1 ... 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 ... 3937